Montilab 10 mg (Tablet)
Medicine Details
| Category | Details |
|---|---|
| Generic | Montelukast sodium |
| Company | Labaid pharma ltd |
| Also available as |
Title
Montilab 10 mg Tablet
Categories
- Medicine
- Healthcare
- Pharmaceutical
Description
Montilab is a selective and orally active leukotriene receptor antagonist indicated for prophylaxis and chronic treatment of asthma, acute prevention of Exercise-Induced Bronchoconstriction (EIB), and relief of symptoms of Allergic Rhinitis (AR) including seasonal and perennial allergic rhinitis.
Indications
- Prophylaxis and chronic treatment of asthma
- Acute prevention of Exercise-Induced Bronchoconstriction (EIB)
- Relief of symptoms of Allergic Rhinitis (AR): Seasonal & Perennial Allergic Rhinitis
Pharmacology
Montelukast is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene receptor (CysLT1), correlating with the pathophysiology of signs and symptoms of asthma and allergic rhinitis.
DosageAndAdministration
- AdultsAndAdolescents: 10 mg tablet once daily
- PediatricPatients:
- 6 to 14 years: 5 mg tablet once daily
- 2 to 5 years: 4 mg tablet once daily
- 6 months to 5 years: 4 mg oral granules once daily
- HepaticInsufficiency: No dosage adjustment required in mild-to-moderate hepatic insufficiency
- RenalInsufficiency: No dosage adjustment recommended in patients with renal insufficiency
- ElderlyUse: No dosage adjustment required
Interaction
Montilab's recommended clinical dose did not have clinically important effects on the pharmacokinetics of other drugs commonly used with no evidence of clinical adverse interactions.
Contraindications
Contraindicated in patients hypersensitive to any component of the product
SideEffects
- Common:
- Diarrhoea
- Fever
- Gastrointestinal discomfort
- Headache
- Nausea
- Vomiting
- Skin reactions
- Upper respiratory tract infection
- Uncommon:
- Akathisia
- Anxiety
- Arthralgia
- Asthenia
- Abnormal behavior
- Depression
- Dizziness
- Drowsiness
- Dry mouth
- Haemorrhage
- Irritability
- Malaise
- Muscle complaints
- Oedema
- Seizure
- Abnormal sensation
- Sleep disorders
- Rare:
- Angioedema
- Concentration impaired
- Disorientation
- Eosinophilic granulomatosis with polyangiitis
- Erythema nodosum
- Hallucination
- Hepatic disorders
- Memory loss
- Palpitations
- Pulmonary eosinophilia
- Suicidal tendencies
- Tremor
PregnancyAndLactation
Should be used during pregnancy only if clearly needed; caution should be exercised when given to a nursing mother
PrecautionsAndWarnings
- ReversalOfBronchospasm: Not indicated for use in the reversal of bronchospasm in acute asthma attacks
- RescueMedication: Patients should have appropriate rescue medication available
- Monotherapy: Should not be used as monotherapy for the treatment and management of exercise induced bronchospasm
- AspirinSensitivity: Not shown to truncate response to aspirin and other non-steroidal anti-inflammatory drugs in aspirin-sensitive asthmatic patients
OverdoseEffects
No adverse experiences in the majority of reports; usual supportive measures are recommended in the event of overdose
TherapeuticClass
Leukotriene receptor antagonists
StorageConditions
- Temperature: Below 30°C
- Protection: From light & moisture
- Safety: Keep out of reach of children
ChemicalStructure
- MolecularFormula: C35H36ClNO3S
- Image: https://medex.com.bd/storage/res/g-res-768-montelukast-sodium-chemical-structure-drK1lRHjspWQ7613gJoZ.svg
FAQs
- Montilab10mgTablet:
- WhatIsIt: Selective and orally active leukotriene receptor antagonist
- Uses: Treatment of asthma or allergic rhinitis
- OnsetOfEffect: 1-3 hours after administration
- DurationOfEffect: Approximately 24 hours
- UseWithFood: May be taken with or without food as prescribed
- PregnancyWarnings: Avoid use unless clearly needed
- GeneralInstructions:
- Take exactly as prescribed
- Do not change dose or stop without doctor's advice
- Not a fast-acting rescue medicine for asthma attacks
- Avoid situations triggering asthma attacks
- Consult doctor if pregnant or breastfeeding